Shields J A, Shields C L
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107.
Trans Pa Acad Ophthalmol Otolaryngol. 1990;42:951-4.
The authors summarize their experience and review the pertinent literature on photocoagulation in the treatment of selected patients with retinoblastoma. Photocoagulation appears to be an appropriate method of management in cases where the tumor is no greater than 3.0 mm in diameter and 2.0 mm in thickness and is confined to the sensory retina, without seeding into the adjacent vitreous. Photocoagulation alone is generally unsuccessful for tumors greater than 4.5 mm in diameter and greater than 2.5 mm in thickness and supplemental treatment with other modalities was often necessary in such cases. Based on personal observations the authors point out certain misconceptions regarding photocoagulation of retinoblastoma and define their current indications and contraindications for this treatment modality.
作者总结了他们的经验,并回顾了有关视网膜母细胞瘤选定患者光凝治疗的相关文献。对于直径不大于3.0毫米、厚度不大于2.0毫米且局限于感觉视网膜、未播散至相邻玻璃体的肿瘤,光凝似乎是一种合适的治疗方法。对于直径大于4.5毫米、厚度大于2.5毫米的肿瘤,单纯光凝通常不成功,在这种情况下通常需要采用其他方式进行补充治疗。基于个人观察,作者指出了有关视网膜母细胞瘤光凝的某些误解,并明确了这种治疗方式目前的适应证和禁忌证。